Advanzeon Solutions, Inc.’s Wholly Owned Subsidiary, Pharmacy Value Management Solutions, Inc., Announces Strategic Relationship with Crank Communications

TAMPA, FL / ACCESSWIRE / August 19, 2019 / Advanzeon Solutions, Inc. (OTC PINK:CHCR)(“Advanzeon”) announced today that its wholly-owned subsidiary, Pharmacy Value Management Solutions, Inc. (collectively, the “Company”), has formed a strategic relationship with Crank Communications.

Crank Communications, a leader in marketing, advertising and public relations, has been retained by the Company to assist in designing and executing a program having as its goal the increasing of public and private awareness, both nationally and in Europe, of the Company’s SleepMaster Solutions™ brand.

Clark A. Marcus, the Company’s Chairman and Chief Executive Officer, stated, “The Company has had a tremendous growth year, which included the material expansion of the Company’s management team, the extension of our sleep apnea services agreement with the Teamsters, being selected by All Aboard America! to screen, test and treat all of its motor coach drivers and employees and being engaged by a national healthcare leader of the DOT’s required medical exams to serve as its preferred national sleep apnea services provider. With a significant number of other accounts on the horizon, management is of the firm belief that engaging a company like Crank Communications represents the next step in our growing evolution, and doing so, greatly enhances the Company’s potential for “closing” more and varied accounts. We are delighted at the arrangement we have reached with Crank Communications and look forward to a long-term relationship with them.”

Brian Margolis, Founder and Managing Partner of Crank Communications, stated, “We are honored at being engaged by the Company to bring them to the next level of national recognition of their brand. Already a national leader in the sleep apnea field, we believe that we can further enhance the Company’s national footprint by bringing even more awareness to the epidemic proportion of sleep apnea. Sleep apnea affects millions of people every day, and if left untreated, can cause high blood pressure, cardiovascular disease, memory problems and a whole host of other life-threatening and non-life-threatening conditions. Moreover, untreated sleep apnea can be responsible for job impairment, motor vehicle crashes and deaths. Simply put, SleepMaster Solutions™ saves lives and lowers the cost of healthcare (in general), and we are proud to associate with the Company in such an important way.”

About Advanzeon Solutions, Inc.

Advanzeon Solutions, Inc. (OTC PINK: CHCR) through its subsidiary, owns and operates the nation’s most complete sleep apnea program, SleepMaster Solutions™ (the “Program”). Headquartered in Tampa, Florida, the Company’s Program is available in all fifty states and Washington D.C. The Program focuses on personalized attention, flexibility, a commitment to high-quality services and innovative approaches that address both the specific needs of clients and changing healthcare industry demands. For more information, visit our website at www.advanzeon.com.

About Crank Communications

Crank Communications, headquartered in Orlando, Florida, is a leading independent full-service marketing communications agency that provides companies a unique fusion of public relations, social media, advertising, marketing, event and digital services. Crank Communications works in both the private and public sector, and with Fortune 500 and start-up organizations alike, in industries including technology, retail, medical, sports and entertainment, non-profit and associations. For more information, visit http://www.crankcommunications.com.

Safe Harbor Statement

This press release contains forward-looking statements that are subject to risks and uncertainties. These forward-looking statements include information about possible or assumed future results of our business, financial condition, liquidity, results of operations, plans and objectives. In some cases, you may identify forward-looking statements by words such as “may,” “should,” “plan,” “intend,” “potential,” “continue,” “believe,” “expect,” “predict,” “anticipate” and “estimate,” the negative of these words or other comparable words. These statements are only predictions. One should not place undue reliance on these forward-looking statements. The forward-looking statements are qualified by their terms and/or important factors, many of which are outside the Company’s control, involve a number of risks, uncertainties and other factors that could cause actual results and events to differ materially from the statements made. The forward-looking statements are based on the Company’s beliefs, assumptions and expectations of our future performance, taking into account information currently available to the Company. These beliefs, assumptions and expectations can change as a result of many possible events or factors, not all of which are known to the Company. Neither the Company nor any other person assumes responsibility for the accuracy or completeness of these statements. The Company will update the information in this press release only to the extent required under applicable securities laws. If a change occurs, the Company’s business, financial condition, liquidity and results of operations may vary materially from those expressed in the aforementioned forward-looking statements.

Contact:

Brianna Bujnowski
Crank Communications
407-830-7312
brianna@crankcommunications.com
www.Advanzeon.com

SOURCE: Advanzeon Solutions, Inc.

View source version on accesswire.com:
https://www.accesswire.com/556635/Advanzeon-Solutions-Incs-Wholly-Owned-Subsidiary-Pharmacy-Value-Management-Solutions-Inc-Announces-Strategic-Relationship-with-Crank-Communications

Staff

Recent Posts

Phio Pharmaceuticals Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…

54 minutes ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

3 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

3 hours ago

Hallmark Adds Senior Executives to Enhance Customer Success and Strategic Partnerships

New leadership roles highlight Hallmark’s unique vendor-neutral approach to helping health systems build flexible, efficient,…

3 hours ago

CARESYNTAX ANNOUNCES 2024 HIGHLIGHTS

 Company Celebrates Continued Worldwide Progress Toward Data-Driven Surgery SAN FRANCISCO and BERLIN, Dec. 23, 2024…

3 hours ago

Medit Launches a Mobile App, MEDIT M, to Revolutionize Digital Dental Workflows

SEOUL, South Korea, Dec. 23, 2024 /PRNewswire/ -- Medit has launched a mobile app, MEDIT…

3 hours ago